Non–Small Cell Lung Cancer: Streamlining Turnaround Times in Biomarker Testing
Expert perspectives on improving turnaround times in genomic testing for lung cancer, covering strategies, challenges, and the significance of liquid biopsy in optimizing patient care.
Precision Medicine Biomarker Testing Small Cell Lung Cancer Streamlining Turnaround Times Non Small Cell Lung Cancer Lung Cancer
Source: onclive.com